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1. Mismatch discrimination 
 
Table S1. Tm values from UV-melting curves (260 nm) of ON1 and DNA1 in duplex with 
complementary DNA incorporating one mismatch. 
Entry Duplex X=A X=T X=G X=C 
ON1 5’-d(GGA TGT TCt CGA)-3’ 
50.3 41.0 45.2 37.3 
DNA 5´-d(TCG XGA ACA TCC)-3' 
DNA1 5’-d(GGA TGT TCT CGA)-3’ 
49.1 38.3 40.5 36.7 
DNA 5´-d(TCG XGA ACA TCC)-3' 
Experimental conditions: total strand conc. 2 μM in 10 mM NaH2PO4, 150 mM NaCl, pH 7.0 
2. Molecular modeling 
Figure S1: The two minimum energy conformers of 7’,5’-bc-5-MeC nucleosides a): C6’-endo 
and b): C6’-exo. Potential energy surfaces of c): the C6’-endo conformer and d): the C6’-exo 
conformer. 
Figure S2: The two minimum energy conformers of 7’,5’-bc-A nucleosides a): C6’-endo and 
b): C6’-exo. Potential energy surfaces of c): the C6’-endo conformer and d): the C6’-exo 
conformer 
Figure S3: The two minimum energy conformers of 7’,5’-bc-G nucleosides a): C6’-endo and 
b): C6’-exo. Potential energy surfaces of c): the C6’-endo conformer and d): the C6’-exo 
conformer 
Table S2. Energy of formation in the gas phase and aqueous phase of the four 7’,5’-bc-DNA 
nucleosides. Values are in kcal/mol. 
Nucleoside 
C6’-endo conformer C6’-exo conformer 
Gas phase Aqueous phase Gas phase Aqueous phase 
7’,5’-bc-T -594230.17 -594256.03 -594231.56 -594255.98 
7’,5’-bc-5-MeC -581770.53 -581802.00 -581771.17 -581801.54 
7’,5’-bc-A -602395.55 -602424.63 -602396.93 -602424.62 
7’,5’-bc-G -649378.33 -649417.69 -649379.88 -649417.43 
 
 Figure S4: Orientation of the  angle for the 7’,5’-bc-DNA residue in ON2, ON5, ON6 and 
ON7 during the simulation. An angle below 130° indicate C6’-exo conformation and an angle 














































3. Characterization of oligonucleotides 
 
Table S3. List of oligonucleotides and results of the characterization. 
  [a]A,G,T,C denote natural 2′-deoxynucleosides; a,t,g,c corresponds to modified nucleosides, c 
stands for the modified 5-methylcytosine nucleoside. 
 [b] Mobile phase “A”: 25 mM Trizma in H2O, pH 8.0; Mobile phase “B”: 25 mM Trizma, 
1.25 M NaCl in H2O, pH 8.0; Analyses were performed by using a linear gradient of B in A, 
over 20 min, with a flow of 1 ml/min. 
 
4. Evidence of a bimolecular association between ON13 and ON14 
 
To confirm the bimolecular association between ON13 and ON14, the spectroscopic 
properties of the homo 7’,5’-bc-DNA duplex were compared with its constituting separated 
single strands. Unlike the UV-melting curve of the ON13•ON14 duplex, the UV-melting 
curves of the single strands do not display a sigmoidal melting behavior (Figure S5, left). 
Furthermore, the CD-spectra of the single strands do not reproduce the features of the homo 
7’,5’-bc-DNA duplex (Figure S5, right). This data unambiguously confirms the formation of a 












ON1 5′-d(GGATGTTCtCGA)-3′ B: 15 → 55% 12.15 96.2 3700.67 3701.7 
ON2 5′-d(GGAtGTTCTCGA)-3′ B: 15 → 55% 12.25 95.4 3700.67 3701.7 
ON3 5′-d(GGATGttCTCGA)-3′ B: 15 → 55% 11.85 90.2 3726.68 3727.7 
ON4 5′-d(GGATGTTcTCGA)-3′ B: 15 → 55% 12.52 96.1 3714.68 3715.7 
ON5 5′-d(GGATGTTCTcGA)-3′ B: 15 → 55% 12.91 93.2 3714.68 3715.7 
ON6 5´-d(GGaTGTTCTCGA)-3′ B: 15 → 55% 12.63 90.3 3700.67 3701.7 
ON7 5´-d(GGATgTTCTCGA)-3′ B: 15 → 55% 12.79 96.7 3700.67 3701.7 
ON8 5′-d(GGATGTTcTCGA)-3′ B: 15 → 55% 12.67 98.4 3700.67 3701.7 
ON9 5′-d(GGATGTTCTcGA)-3′ B: 15 → 55% 12.75 99.2 3700.67 3701.7 
ON10 5′-d(GGATGTTcTcGA)-3′ B: 15 → 55% 12.82 99.3 3726.68 3727.7 
ON11 5′-d(GCAtttttACCG)-3′ B: 15 → 55% 11.88 98.1 3739.71 3740.7 
ON12 5′-d(ttttctcct)-7′ B: 7 → 32% 13.77 90.4 2905.65 2906.6 
ON13 5´-d(ggatgttctcga)-7′ B: 15 → 35% 15.00 95.4 4014.87 4015.9 
ON14 5´-d(tcgagaacatcc)-7′ B: 15 → 35% 13.43 95.0 3980.91 3981.9 
ON15 5′-d(cctacaagagct)-7′ B: 15 → 35% 14.98 94.8 3980.91 3981.9 
  
Figure S5: (Left) UV-melting curves (260 nm) of the homo 7’,5’-bc-DNA duplex 
(ON13•ON14) in comparison with the corresponding separated single strands. Experimental 
conditions: total strand conc. µ in 10 mM NaH2PO4, 150 mM NaCl, pH 7.0; (Right) CD-
spectra of the homo 7’,5’-bc-DNA duplex (ON13•ON14) in comparison with the 
corresponding separated single strands. Experimental conditions: total strand conc. 2µM in 10 
mM NaH2PO4, 150 mM NaCl, pH 7.0, 10°C. 
 
5. Synthesis of cytosine phosphoramidite building block 
 
(3’S,5’R,7’R)-1-{7’-[(tert-butyldiphenylsilyl)oxy]-2’,3’-Dideoxy-3’,5’-ethano-β-D-
ribofuranosyl} uracil (26) : 
  
To a solution of the sugar 6 (669 mg, 1.62 mmol) in dry DCM (13 mL) was added 2,6-
lutidine (0.94 mL, 8.10 mmol) at 0°C. After stirring for 20 min at 0°C, TMSOTf (0.89 mL, 
4.86 mmol) was added dropwise and then the solution was allowed to warm to rt and was 
stirred for an additional 3 h. The reaction was then quenched by addition of satd NaHCO3 (20 
mL). The organic phase was separated and aqueous phase was further extracted with DCM (2 
X 20 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. 
The crude product was dissolved in dry DCM (12 mL) and then uracil (545 mg, 4.86 mmol) 
and BSA (1.8 mL, 7.29 mmol) were added at rt. After stirring for 60 min at rt, the resulting 
fine suspension was cool down to 0°C and N-iodosuccinimide (578 mg, 2.52 mmol) was 




































EtOAc (50 mL) and subsequently washed with a 10% aq solution of Na2S2O3 (30 mL) and 
satd NaHCO3 (30 mL). Aqueous phases were combined and extracted with DCM (2 X 20 
mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The 
crude product was dissolved in dry toluene (15 mL) and then Bu3SnH (0.65 mL, 2.43 mmol) 
and azoisobutyronitrile (AIBN, 13 mg, 0.081 mmol) were added at rt. After heating at 95°C 
for 2 h, the mixture was cool down to rt and MeOH (7 mL) and HCl (1M in water, 1.6 mL, 
1.6 mmol) were added. The solution was further stirred for 15 min and was then diluted with 
satd NaHCO3 (50 mL) and extracted with DCM (3 X 50 mL). The combined organic phases 
were dried over MgSO4, filtered and evaporated. The crude product was purified by CC 
(EtOAc/hexane 4:1) to yield 26 (490 mg, 61% over three steps) as a white foam. 
Data for 26: Rf = 0.15 (EtOAc/hexane 2:1); 
1H NMR (300 MHz, CDCl3) δ 9.95 (br, 1H, H-
N(3)), 7.69 (d, J = 6.4 Hz, 4H, H-arom), 7.54 – 7.39 (m, 7H, H-C(6), H-arom), 5.98 (dd, J = 
9.3, 5.6 Hz, 1H, H-C(1’)), 5.71 (d, J = 8.1 Hz, 1H, H-C(5)), 4.51 (dd, J = 13.7, 6.3 Hz, 2H, H-
C(4’), H-C(5’)), 4.14 (br, 1H, H-C(7’)), 3.25 (br, 1H, OH), 2.74 (dd, J = 17.1, 8.7 Hz, 1H, H-
C(3’)), 2.26 – 1.87 (m, 3H, H-C(2’), H-C(6’)), 1.49 – 1.19 (m, 1H, H-C(2’)), 1.12 (s, 9H, 
(CH3)3-C-Si); 
13C NMR (75 MHz, CDCl3) δ 163.65 (C(4)), 150.46 (C(2)), 139.85 (C(6)), 
135.69, 135.66 (CH-arom), 133.71, 133.42 (C-arom), 129.98, 129.93, 127.85, 127.81 (CH-
arom), 102.84 (C(5)), 86.17 (C(1’)), 81.83 (C(4’)), 76.94 (C(7’)), 72.45 (C(5’)), 50.09 (C(3’)), 
40.93 (C(6’)), 35.83 (C(2’)), 26.91 (CH3)3-C-Si), 19.03 (CH3)3-C-Si); ESI+-HRMS m/z calcd 
for C27H32O5N2NaSi ([M + Na]
+) 515.1973, found 515.1963. 
 
(3’S,5’R,7’R)-1-{7’-[(tert-butyldiphenylsilyl)oxy]-2’,3’-Dideoxy-3’,5’-ethano-5’-O-[(4,4’-
dimethoxytriphenyl)methyl]-β-D-ribofuranosyl} uracil (27) :  
 
To a solution of nucleoside 26 (438 mg, 0.889 mmol) in dry pyridine (7 mL) was added 
DMTr-Cl (1.20 g, 3.55 mmol) at rt. The solution was stirred for 1 day at rt and then was 
diluted with satd NaHCO3 (30 mL) and extracted with DCM (3 X 40 mL). The combined 
organic phases were dried over MgSO4, filtered and evaporated. The crude product was 
purified by CC (1.5% MeOH in DCM, +0.5 % Et3N) to yield 27 (601 mg, 80%) as a yellow 
foam. 
Data for 27: Rf = 0.48 (EtOAc/hexane 2:1); 
1H NMR (300 MHz, CDCl3) δ 9.26 (br, 1H, H-
N(3)), 7.84 (d, J = 8.1 Hz, 1H, H-C(6)), 7.40 – 7.08 (m, 19H, H-arom), 6.69 (dd, J = 8.8, 4.9 
Hz, 4H, H-arom), 5.70 (dd, J = 7.8, 5.8 Hz, 1H, H-C(1’)), 5.49 (dd, J = 8.1, 1.5 Hz, 1H, H-
C(5)), 4.24 – 4.11 (m, 1H, H-C(5’)), 4.05 – 3.95 (m, 1H, H-C(4’)), 3.65 (d, J = 1.7 Hz, 6H, 
MeO), 3.62 (d, J = 3.0 Hz, 1H, H-C(7’)), 2.41 (dd, J = 17.2, 8.5 Hz, 1H, H-C(3’)), 2.24 (ddd, 
J = 13.5, 10.2, 5.7 Hz, 1H, H-C(2’)), 1.39 – 1.24 (m, 1H, H-C(6’)), 1.04 (dd, J = 13.1, 5.7 Hz, 
1H, H-C(6’)), 0.89 (dt, J = 13.8, 8.3 Hz, 1H, H-C(2’)), 0.81 (s, 9H, (CH3)3-C-Si); 13C NMR 
(75 MHz, CDCl3) δ 163.58 (C(4)), 158.66 (MeO-C-arom), 150.38 (C(2)), 145.61 (C-arom), 
139.92 (C(6)), 136.71, 136.56(C-arom), 135.61, 135.55 (CH-arom), 133.55, 133.41 (C-arom), 
130.30, 129.92, 129.84, 128.16, 127.90, 127.74, 127.67, 126.90, 113.19, 113.15 (CH-arom), 
102.12 (C(5)), 87.41 (C(Ph)3), 86.80 (C(1’)), 82.32 (C4’)), 75.54 (C(7’)), 74.41 (C(5’)), 55.23 
(MeO-DMTr), 50.05 (C(3’)), 38.49 (C(6’)), 37.53 (C(2’)), 26.81 (CH3)3-C-Si), 18.99 (CH3)3-
C-Si); ESI+-HRMS m/z calcd for C48H50O7N2NaSi ([M + Na]
+) 817.3279, found 817.3286. 
 
(3’S,5’R,7’R)-1-{7’-[(tert-butyldiphenylsilyl)oxy]-2’,3’-Dideoxy-3’,5’-ethano-5’-O-[(4,4’-
dimethoxytriphenyl)methyl]-β-D-ribofuranosyl} cytosine (28) :  
 
To a suspension of 1,2,4-triazole (1.83g, 26.5 mmol) in dry MeCN (70 mL), at 0°C, were 
added POCl3 (0.57 mL, 6.05 mmol) followed by Et3N (4.2 mL, 30.2 mmol). The suspension 
was stirred for 30 min at 0° C and then a solution of the nucleoside 27 (601 mg, 0.756 mmol) 
in dry MeCN (4 mL) was added at 0°C. After for 4 h of stirring at rt, the reaction was 
quenched with addition of satd NaHCO3 (20 mL), MeCN removed under reduced pressure 
and the resulting mixture diluted with satd NaHCO3 (30 mL) and extracted with DCM (3 X 
60 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The 
crude product was then dissolved in a mixture of 1,4-dioxane (18 mL) and concd NH4OH (18 
mL). After stirring for 3 h at rt, the mixture was reduced to half of the volume in vacuo, 
diluted with satd NaHCO3  (30 mL) and extracted with DCM (3 X 30 mL). The combined 
organic phases were dried over MgSO4, filtered and evaporated. The crude product was 
purified by CC (5% MeOH in DCM, +0.5 % Et3N) to yield 28 (520 mg, 87%) as a white 
foam. 
Data for 28: Rf = 0.41 (10% MeOH in DCM); 
1H NMR (300 MHz, CDCl3) δ 7.96 (d, J = 7.4 
Hz, 1H,H-C(6)), 7.45 (d, J = 7.4 Hz, 2H, H-arom), 7.38 – 7.08 (m, 17H, H-arom), 6.73 (dd, J 
= 8.7, 4.7 Hz, 4H, H-arom), 5.73 (t, J = 8.6 Hz, 2H, H-C(5), H-C(1’)), 4.32 – 4.16 (m, 1H, H-
C(5’)), 4.03 (t, J = 5.6 Hz, 1H, H-C(4’)), 3.66 (d, J = 0.9 Hz, 6H, MeO), 3.61 (d, J = 2.9 Hz, 
1H, H-C(7’)), 2.50 – 2.33 (m, 2H, H-C(2’), H-C(3’)), 1.47 – 1.28 (m, 1H, H-C(6’)), 1.03 (dd, 
J = 12.9, 5.6 Hz, 1H, H-C(6’)), 0.92 – 0.75 (m, 10H, H-C(2’), (CH3)3-C-Si); 13C NMR (75 
MHz, CDCl3) δ 165.78 (C(4)), 158.59 (MeO-C-arom), 155.94 (C(2)), 145.88 (C-arom), 
140.68 (C(6)), 136.93, 136.78 (C-arom), 135.59, 135.53 (CH-arom), 133.60, 133.54 (C-
arom), 130.31, 129.86, 129.77, 128.15, 127.88, 127.71, 127.64, 126.79, 113.18, 113.14 (CH-
arom), 94.53 (C(5)), 87.55 (C(Ph)3), 87.22 (C(1’)), 82.23 (C(4’)), 75.76 (C(7’)), 74.68 
(C(5’)), 55.21 (MeO-DMTr), 50.18 (C(3’)), 38.25 (C(6’)), 38.08 (C(2’)), 26.83 (CH3)3-C-Si), 
19.00 (CH3)3-C-Si); ESI
+-HRMS m/z calcd for C48H52O6N3Si ([M + H]




5’-O-[(4,4’-dimethoxytriphenyl)methyl]-β-D-ribofuranosyl} cytosine (29) :  
 
To a solution of nucleoside 28 (519 mg, 0.653 mmol) in dry DMF (15 mL) were added Et3N 
(110 μL, 0.784 mmol) followed by Bz2O (370 mg, 1633 mmol) at rt and the solution was 
stirred overnight. Then the solution was quenched by careful addition of satd NaHCO3 (60 
mL) and extracted with DCM (3 X 70 mL). The combined organic phases were dried over 
MgSO4, filtered and evaporated. The crude product was purified by CC (hexane/EtOAc 2:3, 
+0.5 % Et3N) to yield 29 (580 mg, 99%) as a white foam. 
Data for 29: Rf = 0.51 (EtOAc); 
1H NMR (300 MHz, CDCl3) δ 8.61 (d, J = 7.4 Hz, 1H, H-
C(6)), 7.81 (d, J = 7.5 Hz, 2H, H-arom), 7.49 – 7.13 (m, 24H, H-arom, H-C(5)), 6.77 (dd, J = 
8.5, 4.4 Hz, 4H, H-arom), 5.73 (t, J = 6.4 Hz, 1H, H-C(1’)), 4.39 – 4.20 (m, 1H, H-C(5’)), 
4.05 (t, J = 6.1 Hz, 1H, H-C(4’)), 3.70 (s, 6H, MeO), 3.63 (d, J = 2.3 Hz, 1H, H-C(7’)), 2.72 – 
2.55 (m, 1H, H-C(2’)), 2.48 (dd, J = 16.0, 8.4 Hz, 1H, H-C(3’)), 1.42 – 1.29 (m, 1H, H-
C(6’)), 1.19 – 1.11 (m, 1H, H-C(6’)), 1.07 – 0.96 (m, 1H, H-C(2’)), 0.85 (s, 9H, (CH3)3-C-Si). 
13C NMR (75 MHz, CDCl3) δ 166.64 (CONH), 162.25 (C(4)), 158.70 (MeO-C-arom), 154.84 
(C(2)), 145.71 (C-arom), 144.84 (C(6)), 136.74, 136.67 (C-arom), 135.59, 135.51 (CH-arom), 
133.52, 133.42, 133.24 (C-arom), 133.11, 130.30, 129.92, 129.85, 129.02, 128.12, 127.97, 
127.76, 127.68, 127.61, 126.94, 113.25, 113.22(CH-arom), 96.22 (C(5)), 89.07 (C(Ph)3), 
87.53 (C(1’)), 83.46 (C(4’)), 75.59 (C(7’)), 74.71 (C(5’)), 55.24 (MeO-DMTr), 50.35 (C(3’)), 
38.61 (C(6’)), 38.15 (C(2’)), 26.82 (CH3)3-C-Si), 19.00 (CH3)3-C-Si). ESI+-HRMS m/z calcd 
for C55H56O7N3Si ([M + H]
+) 898.3882, found 898.3898. 
 
(3’S,5’R,7’R)- N4-Benzoyl-1-{-2’,3’-Dideoxy-3’,5’-ethano-7’-hydroxy-5’-O-[(4,4’-
dimethoxytriphenyl)methyl]-β-D-ribofuranosyl} cytosine (30) :  
 
To a solution of 29 (580 mg, 0.648 mmol) in dry THF (14 mL) was added TBAF (1M in 
THF, 3.25 mL, 3.25 mmol) at rt. The solution was stirred for 1 day and then was diluted with 
satd NaHCO3 (50 mL) and extracted with DCM (3 X 40 mL). The combined organic phases 
were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (3% 
MeOH in DCM, +0.5 % Et3N) to yield 30 (366 mg, 85%) as a white foam. 
Data for 30: Rf = 0.31 (5% MeOH in DCM); 
1H NMR (300 MHz, CDCl3) δ 8.90 (br, 1H, 
NH), 8.73 (d, J = 7.5 Hz, 1H, H-C(6)), 7.82 (d, J = 7.3 Hz, 2H, H-arom), 7.55 – 7.31 (m, 10H, 
H-arom, H-C(5)), 7.28 – 7.09 (m, 3H, H-arom), 6.76 (dd, J = 8.8, 1.7 Hz, 4H, H-arom), 5.73 
(t, J = 6.3 Hz, 1H, H-C(1’)), 4.28 – 4.13 (m, 1H, H-C(5’)), 3.83 (t, J = 6.0 Hz, 1H, H-C(4’)), 
3.75 (d, J = 3.6 Hz, 1H, H-C(7’)), 3.70 (s, 6H, MeO), 2.86 (d, J = 14.7 Hz, 1H, H-C-(2’)), 
2.54 (dd, J = 17.4, 7.4 Hz, 1H, H-C(3’)), 1.68 – 1.55 (m, 1H, H-C(6’)), 1.45 – 1.13 (m, 3H, 
H-C(2’), H-C(6’), OH); 13C NMR (75 MHz, CDCl3) δ 166.63 (CONH), 162.34 (C(4)), 158.65 
(MeO-C-arom), 155.00 (C(2)), 145.62 (C-arom), 145.11 (C(6)), 136.72, 136.64, 133.16 (C-
arom), 130.25, 129.02, 128.12, 127.93, 127.61, 126.95, 113.20 (CH-arom), 96.24 (C(5)), 
89.20 (C(Ph)3), 87.48 (C(1’)), 83.40 (C(4’)), 74.50, (C(5’)) 73.90 (C(7’)), 55.25 (MeO-
DMTr), 50.05 (C(3’)), 38.90 (C(6’)), 38.40 (C(2’)); ESI+-HRMS m/z calcd for C39H38O7N3 






(31) :  
 
To a solution of the nucleoside 30 (67 mg, 0.101 mmol) and 5-(ethylthio)-1H-tetrazole (22 
mg, 0.17 mmol) in dry DCM (3 mL) was added dropwise 2-cyanoethyl N,N,N′,N′-
tetraisopropylphosphordiamidite (65 μL, 0.20 mmol) at rt. After stirring for 40 min, the 
reaction mixture was diluted with DCM (20 mL) and washed with satd NaHCO3 (2 X 15 mL) 
and satd NaCl (15 mL). Aqueous phases were combined and extracted with DCM (20 mL). 
The combined organic phases were dried over MgSO4, filtered and evaporated. The crude 
product was purified by CC (EtOAc, +0.5 % Et3N) to yield 31 (75 mg, mixture of two 
isomers, 86%) as a white foam. 
Data for 31: Rf = 0.67 (4% MeOH in DCM); 
1H NMR (300 MHz, CDCl3) δ 8.88 (s, 1H, NH), 
8.79 (d, J = 7.5 Hz, 1H, H-C(6)), 7.93 (d, J = 7.5 Hz, 2H, H-arom), 7.67 – 7.40 (m, 10H, H-
arom, H-C(5)), 7.39 – 7.22 (m, 3H, H-arom), 6.93 – 6.79 (m, 4H, H-arom), 5.97 – 5.77 (m, 
1H, H-C(1’)), 4.22 (dt, J = 14.5, 5.6 Hz, 1H, H-(5’)), 3.98 – 3.84 (m, 2H, H-C(4’), H-C(7’)), 
3.82 (s, 6H, MeO), 3.66 (ddd, J = 16.8, 13.5, 6.7 Hz, 2H, OCH2CH2CN), 3.53 – 3.37 (m, 2H, 
(Me2CH)2N), 3.14 – 2.93 (m, 1H, H-C(2’)), 2.84 – 2.66 (m, 1H, H-C(3’)), 2.53 (dt, J = 12.4, 
6.3 Hz, 2H, OCH2CH2CN), 1.83 – 1.56 (m, 2H, H-C(6’)), 1.46 (td, J = 14.1, 7.0 Hz, 1H, H-
C(2’)), 1.18 – 0.97 (m, 12H, (Me2CH)2N); 13C NMR (75 MHz, CDCl3) δ 166.70 (CONH), 
162.32, 162.28 (C(4)), 158.68 (MeO-C-arom), 154.93 (C(2)), 145.53 (C-arom), 144.95, 
144.89 (C(6)), 136.69, 136.63, 136.56, 136.52, 133.24 (C-arom), 133.10, 130.24, 130.20, 
129.01, 128.10, 127.94, 127.60, 126.96 (CH-arom), 117.53 (OCH2CH2CN), 113.20 (CH-
arom), 96.24 (C(5)), 89.15, 89.10 (C(Ph)3), 87.55, 87.54 (C(1’)), 83.11, 83.04 (C(4’)), 75.93, 
75.37 ( JC,P = 16.7, 15.5 Hz, C(7’)), 74.48 (C(5’)), 58.25, 57.99 (JC,P = 17.9, 18.1 Hz 
OCH2CH2CN), 55.27, 55.24 (MeO-DMTr), 49.27, 49.03 (JC,P = 3.1, 4.8 Hz, C(3’)), 43.15, 
42.98 ((Me2CH)2N), 38.89, 38.80 (C(2’)), 37.44, 37.24 ( JC,P = 5.2, 3.2 Hz, C(6’)), 24.58, 
24.54, 24.48, 24.45, 24.35 (5s, Me2CH)2N), 20.33, 20.24 (JC,P = 5.8, 5.7 Hz, OCH2CH2CN); 
31P NMR (121 MHz, CDCl3) δ 147.19, 146.94; ESI+-HRMS m/z calcd for C48H55O8N5P ([M 
+ H]+) 860.3783, found 860.3791. 
6. Synthesis of 7’-O-p-nitrobenzoyl-7’,5’-bc-T 
 
(3’S,5’R,7’R)-1-{2’,3’-Dideoxy-3’,5’-ethano-7’-O-(4-nitrobenzoate)-5’-O-[(4,4’-
dimethoxytriphenyl)methyl]-β-D-ribofuranosyl} thymine (32) : 
 
To a solution of nucleoside 11 (100 mg, 0.175 mmol) and 4-dimethylaminopyridine (26 mg, 
0.21 mmol) in dry DCM (8 mL) was added 4-nitrobenzoyl chloride (59 mg, 0.315 mmol) at 
rt. After stirring for 6 h, the reaction was quenched by addition of satd NaHCO3 (5 mL). The 
mixture was then diluted with satd NaHCO3 (15 mL) and extracted with DCM (3 X 15 mL). 
The combined organic phases were dried over MgSO4, filtered and evaporated. The crude 
product was purified by CC (2.5% MeOH in DCM, +0.5 % Et3N) to yield 32 (98 mg, 78%) as 
a white foam, containing traces of Et3N. 
Data for 32: Rf = 0.42 (5% MeOH in DCM); 
1H NMR (300 MHz, CDCl3) δ 8.26 (t, J = 7.3 
Hz, 3H, H-arom, HN(3)), 8.00 (d, J = 8.9 Hz, 2H, H-arom), 7.72 (d, J = 1.0 Hz, 1H, H-C(6)), 
7.55 (d, J = 6.9 Hz, 2H, H-arom), 7.44 (dd, J = 8.8, 6.6 Hz, 4H, H-arom), 7.35 – 7.18 (m, 3H, 
H-arom), 6.83 (dd, J = 9.0, 2.6 Hz, 4H, H-arom), 6.01 (dd, J = 8.2, 5.2 Hz, 1H, H-C(1’)), 4.96 
(d, J = 3.3 Hz, 1H, H-C(7’)), 4.33 – 4.24 (m, 1H, H-C(4’)), 4.24 – 4.13 (m, 1H, H-C(5’)), 
3.78 (d, J = 0.9 Hz, 6H, MeO), 2.92 – 2.72 (m, 2H, H-C(3’), H-C(2’)), 1.81 (d, J = 0.6 Hz, 
3H, Me-C(5)), 1.79 – 1.62 (m, 2H, H-C(6’)), 1.22 (d, J = 5.9 Hz, 1H, H-C(2’)); 13C NMR (75 
MHz, CDCl3) δ 164.05, 163.84 (C(4), CO2R), 158.81 (MeO-C-arom), 150.64, 150.52 (O2N-
C-arom, C(2)), 145.29, 136.43, 136.34 (C-arom), 135.18 (C(6)), 130.62, 130.20, 130.17, 
128.16, 128.01, 127.15, 123.58, 113.30, 113.27 (C-arom), 111.17 (C(5)), 87.53 (C(Ph)3), 
86.29 (C(1’)), 81.59 (C(4’)), 78.65 (C(7’)), 74.16 (C(5’)), 55.26 (MeO-DMTr), 47.07 (C(3’)), 
37.35 (C(2’)), 35.71 (C(6’)), 12.51 (Me-C(5)); ESI+-HRMS m/z calcd for C40H37O10N3Na 




thymine (33):  
 
To a solution of 32 (60 mg, 0.083 mmol) in a mixture of dry DCM (1 mL) and MeOH (0.4 
mL), was added dropwise dichloroacetic acid (0.2 mL) at rt. After stirring for 3 h, the mixture 
was then diluted with satd NaHCO3 (15 mL) and extracted with DCM (3 X 10 mL). The 
combined organic phases were dried over MgSO4, filtered and evaporated. The crude product 
was purified by CC (5% MeOH in DCM) to yield 33 (29 mg, 84%) as a white foam. Crystals 
suitable for X-ray analysis were obtain by recrystallization in a mixture of H2O/MeOH. 
Data for 33: Rf = 0.18 (5% MeOH in DCM); 
1H NMR (400 MHz, DMSO) δ 11.33 (s, 1H, H-
N(3)), 8.34 (d, J = 8.8 Hz, 2H, H-arom), 8.27 – 8.13 (m, 2H, H-arom), 7.78 (s, 1H, H-C(6)), 
5.96 (dd, J = 9.3, 5.6 Hz, 1H, H-C(1’)), 5.18 (t, J = 3.8 Hz, 1H, H-C(7’)), 5.12 (d, J = 6.0 Hz, 
1H, OH), 4.33 (dd, J = 7.3, 4.7 Hz, 1H, H-C(4’)), 4.27 (td, J = 10.5, 5.5 Hz, 1H, H-C(5’)), 
2.90 (dd, J = 17.2, 8.5 Hz, 1H, H-C(3’)), 2.58 – 2.46 (m, 1H, H-C(2’)), 2.30 (ddd, J = 13.8, 
8.8, 5.3 Hz, 1H, H-C(6’)), 2.03 (dd, J = 9.6, 4.2 Hz, 1H, H-C(6’)), 1.92 – 1.76 (m, 4H, H-
C(2’), Me-C(5)); 13C NMR (101 MHz, DMSO) δ 164.33, 164.23 (C(4), CO2R), 150.91, 
150.75 (O2N-C-arom, C(2)), 136.79 (C-arom), 135.69 (C(6)), 131.20, 124.32 (CH-arom), 
109.89 (C(5)), 85.31 (C(1’)), 81.48 (C(4’)), 80.07 (C(7’)), 71.72 (C(5’)), 47.18 (C(3’)), 37.77 
(C(6’)), 35.48 (C(2’)), 12.66 12.58 (Me-C(5)); ESI+-HRMS m/z calcd for C19H20O8N3 ([M + 
H]+) 418.1245, found 418.1242. 
  
7. NMR spectra  
Ethyl (E and Z, 1‘R,5’S,7’R)-(7’-hydroxy-3’,3’-dimethyl-2‘,4‘-dioxabicyclo[3.3.0]oct-6‘-






































3’,5’-ethano-5’-O-[(4,4’-dimethoxytriphenyl)methyl]-β-D-ribofuranosyl} thymine  (12) :  
 
 
   
(3’S,5’R,7’R)-N4-Benzoyl-1-{2’,3’-Dideoxy-3’,5’-ethano-7’-hydroxy-5’-O-[(4,4’-







   
(3aR,4R,6R,6aS)-4-((tert-butyldiphenylsilyl)oxy)-2-methoxyhexahydro-2H-











































































(31) :  
 
 
   
(3’S,5’R,7’R)-1-{2’,3’-Dideoxy-3’,5’-ethano-7’-O-(4-nitrobenzoate)-5’-O-[(4,4’-




thymine (33):  
 
 










10. Crystal-Structure Determination.  
A colorless transparent crystal of [C19H19N3O8] (33) was mounted in air and used for X-ray structure 
determination at ambient conditions. All measurements were made on a Oxford Diffraction SuperNova area-
detector diffractometer1 using mirror optics monochromated Mo Kα radiation (λ = 0.71073 Å) and Al filtered.2 
The unit cell constants and an orientation matrix for data collection were obtained from a least-squares 
refinement of the setting angles of reflections in the range 2.° < θ < 27.°. A total of 530 frames were collected 
using ω scans, with 2.5+2.5 seconds exposure time, a rotation angle of 1° per frame, a crystal-detector distance 
of 65.1 mm, at T = 173(2) K.  
 
Data reduction was performed using the CrysAlisPro2 program. The intensities were corrected for Lorentz and 
polarization effects, and an absorption correction based on the multi-scan method using SCALE3 ABSPACK in 
CrysAlisPro2 was applied. Data collection and refinement parameters are given in Table S3. 
 
The structure was solved by direct methods using SHELXS-973, which revealed the positions of all non-hydrogen 
atoms of the title compound. The non-hydrogen atoms were refined anisotropically. All H-atoms were placed in 
geometrically calculated positions and refined using a riding model where each H-atom was assigned a fixed 
isotropic displacement parameter with a value equal to 1.2 Ueq of its parent atom. 
Refinement of the structure was carried out on F2 using full-matrix least-squares procedures, which minimized 
the function Σw(Fo2 – Fc2)2. The weighting scheme was based on counting statistics and included a factor to 
downweight the intense reflections. All calculations were performed using the SHELXL-973 program. 
Table S4.  Crystal data and structure refinement for 33. 
Identification code  shelx 
Empirical formula  C19 H19 N3 O8 
Formula weight  417.37 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 7.0712(2) Å α= 90°. 
 b = 6.48123(16) Å β= 98.062(3)°. 
 c = 20.4085(6) Å γ = 90°. 
Volume 926.08(4) Å3 
Z 2 
Density (calculated) 1.497 Mg/m3 
Absorption coefficient 0.119 mm-1 
F(000) 436 
Crystal size 0.5326 x 0.308 x 0.1151 mm3 
Theta range for data collection 2.016 to 27.110°. 
Index ranges -8<=h<=8, -7<=k<=8, -24<=l<=24 
Reflections collected 6928 
Independent reflections 3651 [R(int) = 0.0200] 
Completeness to theta = 25.000° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.987 and 0.963 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3651 / 1 / 274 
Goodness-of-fit on F2 1.059 
Final R indices [I>2sigma(I)] R1 = 0.0344, wR2 = 0.0772 
R indices (all data) R1 = 0.0387, wR2 = 0.0808 
Absolute structure parameter -0.9(5) 
Extinction coefficient 0.009(2) 
Largest diff. peak and hole 0.212 and -0.236 e.Å-3 
 
Table S5.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 33.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 299(3) 9337(4) 5451(1) 23(1) 
C(2) -691(3) 9335(4) 4821(1) 23(1) 
C(3) 336(3) 9322(4) 4292(1) 22(1) 
C(4) 2321(3) 9309(4) 4404(1) 22(1) 
C(5) 3277(3) 9325(5) 5046(1) 29(1) 
C(6) 2268(4) 9340(5) 5579(1) 28(1) 
C(7) 3525(3) 9206(4) 3858(1) 25(1) 
C(8) 3594(4) 8752(4) 2714(1) 21(1) 
C(9) 2317(3) 9258(4) 2072(1) 22(1) 
C(10) 1028(4) 7378(4) 1946(1) 20(1) 
C(11) 2315(3) 5541(4) 2174(1) 21(1) 
C(12) 3971(3) 6427(4) 2674(1) 21(1) 
C(13) 5767(3) 5892(4) 2366(1) 23(1) 
C(14) 5052(3) 4087(4) 1933(1) 21(1) 
C(15) 6152(3) 4715(4) 857(1) 21(1) 
C(16) 6955(3) 4132(4) 330(1) 21(1) 
C(17) 6949(4) 5439(4) -276(1) 28(1) 
C(18) 7841(3) 2119(4) 341(1) 21(1) 
C(19) 7129(3) 1654(4) 1484(1) 21(1) 
N(1) -777(3) 9330(4) 6018(1) 28(1) 
N(2) 6152(3) 3499(3) 1413(1) 21(1) 
N(3) 7951(3) 1067(3) 938(1) 22(1) 
O(1) 112(3) 9396(5) 6572(1) 54(1) 
O(2) -2519(3) 9246(4) 5910(1) 38(1) 
O(3) 5241(2) 9131(4) 3952(1) 41(1) 
O(4) 2489(2) 9148(3) 3256(1) 22(1) 
O(5) 30(2) 7229(3) 1292(1) 26(1) 
O(6) 3196(2) 4719(3) 1633(1) 22(1) 
O(7) 7248(3) 594(3) 1980(1) 31(1) 
O(8) 8461(3) 1301(3) -127(1) 29(1) 
________________________________________________________________________________ 
 
Table S6.   Bond lengths [Å] and angles [°] for 33. 
_____________________________________________________ 
C(1)-C(2)   1.374(3) 
C(1)-C(6)   1.380(3) 
C(1)-N(1)   1.472(3) 
C(2)-C(3)   1.385(3) 
C(2)-H(2)   0.9500 
C(3)-C(4)   1.390(3) 
C(3)-H(3)   0.9500 
C(4)-C(5)   1.388(3) 
C(4)-C(7)   1.495(3) 
C(5)-C(6)   1.381(3) 
C(5)-H(5)   0.9500 
C(6)-H(6)   0.9500 
C(7)-O(3)   1.203(3) 
C(7)-O(4)   1.340(3) 
C(8)-O(4)   1.464(3) 
C(8)-C(9)   1.519(3) 
C(8)-C(12)   1.534(3) 
C(8)-H(8)   1.0000 
C(9)-C(10)   1.522(4) 
C(9)-H(9A)   0.9900 
C(9)-H(9B)   0.9900 
C(10)-O(5)   1.423(3) 
C(10)-C(11)   1.531(3) 
C(10)-H(10)   1.0000 
C(11)-O(6)   1.442(3) 
C(11)-C(12)   1.553(3) 
C(11)-H(11)   1.0000 
C(12)-C(13)   1.534(3) 
C(12)-H(12)   1.0000 
C(13)-C(14)   1.510(3) 
C(13)-H(13A)   0.9900 
C(13)-H(13B)   0.9900 
C(14)-O(6)   1.428(3) 
C(14)-N(2)   1.452(3) 
C(14)-H(14)   1.0000 
C(15)-C(16)   1.339(3) 
C(15)-N(2)   1.380(3) 
C(15)-H(15)   0.9500 
C(16)-C(18)   1.446(4) 
C(16)-C(17)   1.499(3) 
C(17)-H(17A)   0.9800 
C(17)-H(17B)   0.9800 
C(17)-H(17C)   0.9800 
C(18)-O(8)   1.226(3) 
C(18)-N(3)   1.390(3) 
C(19)-O(7)   1.217(3) 
C(19)-N(2)   1.378(3) 
C(19)-N(3)   1.380(3) 
N(1)-O(1)   1.215(3) 
N(1)-O(2)   1.221(3) 
N(3)-H(3A)   0.8800 
O(5)-H(5A)   0.8400 
 
C(2)-C(1)-C(6)  123.1(2) 
C(2)-C(1)-N(1)  118.9(2) 
C(6)-C(1)-N(1)  118.0(2) 
C(1)-C(2)-C(3)  118.4(2) 
C(1)-C(2)-H(2)  120.8 
C(3)-C(2)-H(2)  120.8 
C(2)-C(3)-C(4)  120.0(2) 
C(2)-C(3)-H(3)  120.0 
C(4)-C(3)-H(3)  120.0 
C(5)-C(4)-C(3)  120.2(2) 
C(5)-C(4)-C(7)  116.8(2) 
C(3)-C(4)-C(7)  123.0(2) 
C(6)-C(5)-C(4)  120.4(2) 
C(6)-C(5)-H(5)  119.8 
C(4)-C(5)-H(5)  119.8 
C(1)-C(6)-C(5)  118.0(2) 
C(1)-C(6)-H(6)  121.0 
C(5)-C(6)-H(6)  121.0 
O(3)-C(7)-O(4)  123.7(2) 
O(3)-C(7)-C(4)  123.4(2) 
O(4)-C(7)-C(4)  112.90(19) 
O(4)-C(8)-C(9)  107.35(19) 
O(4)-C(8)-C(12)  109.1(2) 
C(9)-C(8)-C(12)  104.7(2) 
O(4)-C(8)-H(8)  111.8 
C(9)-C(8)-H(8)  111.8 
C(12)-C(8)-H(8)  111.8 
C(8)-C(9)-C(10)  104.0(2) 
C(8)-C(9)-H(9A)  111.0 
C(10)-C(9)-H(9A) 111.0 
C(8)-C(9)-H(9B)  111.0 
C(10)-C(9)-H(9B) 111.0 
H(9A)-C(9)-H(9B) 109.0 










































O(8)-C(18)-N(3)  119.3(2) 
O(8)-C(18)-C(16) 125.5(2) 
N(3)-C(18)-C(16) 115.2(2) 
O(7)-C(19)-N(2)  123.5(2) 
O(7)-C(19)-N(3)  121.9(2) 
N(2)-C(19)-N(3)  114.6(2) 
O(1)-N(1)-O(2)  123.2(2) 
O(1)-N(1)-C(1)  118.3(2) 











Symmetry transformations used to generate equivalent atoms:  
 
 
Table S7.   Anisotropic displacement parameters (Å2x 103) for 33.  The anisotropic 
displacement factor exponent takes the form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 22(1)  27(1) 21(1)  -5(1) 7(1)  1(1) 
C(2) 19(1)  26(1) 25(1)  -4(1) 2(1)  0(1) 
C(3) 23(1)  25(1) 18(1)  -4(1) 0(1)  0(1) 
C(4) 21(1)  27(1) 19(1)  -6(1) 3(1)  0(1) 
C(5) 19(1)  44(2) 23(1)  -6(1) 1(1)  0(1) 
C(6) 24(1)  41(2) 19(1)  -7(1) 2(1)  0(1) 
C(7) 23(1)  31(1) 19(1)  -6(1) 2(1)  -2(1) 
C(8) 22(1)  26(1) 16(1)  -4(1) 6(1)  1(1) 
C(9) 26(1)  23(1) 18(1)  -1(1) 4(1)  3(1) 
C(10) 19(1)  26(1) 15(1)  -2(1) 4(1)  3(1) 
C(11) 22(1)  23(1) 20(1)  -1(1) 10(1)  -1(1) 
C(12) 22(1)  26(1) 16(1)  2(1) 4(1)  3(1) 
C(13) 20(1)  29(1) 20(1)  -1(1) 3(1)  5(1) 
C(14) 22(1)  24(1) 19(1)  3(1) 7(1)  5(1) 
C(15) 21(1)  21(1) 21(1)  1(1) 3(1)  2(1) 
C(16) 15(1)  28(1) 19(1)  0(1) 1(1)  0(1) 
C(17) 27(1)  36(2) 23(1)  7(1) 8(1)  7(1) 
C(18) 16(1)  29(1) 17(1)  -2(1) 0(1)  -2(1) 
C(19) 18(1)  23(1) 21(1)  0(1) 3(1)  3(1) 
N(1) 25(1)  37(1) 24(1)  -5(1) 6(1)  -1(1) 
N(2) 23(1)  23(1) 19(1)  0(1) 8(1)  4(1) 
N(3) 21(1)  24(1) 23(1)  0(1) 6(1)  9(1) 
O(1) 34(1)  110(2) 19(1)  -7(1) 4(1)  -9(2) 
O(2) 23(1)  59(1) 32(1)  -9(1) 9(1)  0(1) 
O(3) 19(1)  80(2) 23(1)  -7(1) 2(1)  1(1) 
O(4) 21(1)  30(1) 16(1)  -5(1) 4(1)  2(1) 
O(5) 22(1)  36(1) 19(1)  -7(1) 1(1)  6(1) 
O(6) 20(1)  27(1) 20(1)  -5(1) 4(1)  3(1) 
O(7) 37(1)  31(1) 27(1)  10(1) 12(1)  12(1) 
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